American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States focused on joint venture (JV) partnerships with physicians.
As of December 31, 2019, the company owned and operated 246 dialysis clinics in partnership with approximately 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia.
The company operates its dialysis clinics principally through a JV model, in which it partners primarily with local...
American Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States focused on joint venture (JV) partnerships with physicians.
As of December 31, 2019, the company owned and operated 246 dialysis clinics in partnership with approximately 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia.
The company operates its dialysis clinics principally through a JV model, in which it partners primarily with local nephrologists to develop, own and operate dialysis clinics, while the providers of the majority of dialysis services in the United States operate through a combination of wholly owned subsidiaries and joint ventures. Substantially all of the company’s clinics are maintained as separate joint ventures in which the company has the controlling interest and its nephrologist partners and other joint venture partners have a noncontrolling interest. As of December 31, 2019, the company held on average 55% of the interests in its clinics, and its nephrologist partners held 45% of the interests. The company provides patient care and clinical outcomes to patients suffering from end-stage renal disease (ESRD).
Clinics and Services
The company’s clinics primarily provide in-center hemodialysis treatments and ancillary items and services. Hemodialysis lasts approximately 3.5 hours per treatment and is performed at least three times per week. Majority of the company’s clinics also offer services for dialysis patients who prefer and are able to receive either hemodialysis or peritoneal dialysis in their homes. Home-based dialysis services consist of providing equipment and supplies, training, patient monitoring, on-call support services and follow-up assistance. Registered nurses train patients and their families or other caregivers to perform either hemodialysis or peritoneal dialysis at home. For the year ended December 31, 2019, 90% of the treatments the company performed were in-center and 10% were performed with home-based modalities, with peritoneal dialysis and home hemodialysis constituting 9% and 1%, respectively, of the treatments it performed.
The company contracts with third parties to provide ancillary services, such as laboratory testing and pharmacy services. It contracts with a specialized laboratory to provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients. These tests are performed to monitor a patient’s ESRD condition, including the adequacy of dialysis, as well as other medical conditions of the patient. The company works with its laboratory partner to utilize information systems which provide information to physicians and staff members of the dialysis clinics regarding critical outcome indicators. Its clinics contain between 15 and 20 dialysis stations, one or more nurses’ stations, a patient waiting area, examination rooms, a supply room, a water treatment space to purify water used in hemodialysis treatments, staff work areas, offices and a staff lounge. The company’s clinics are also outfitted with patient-friendly features, including heated massaging chairs, wireless internet and individual television sets.
Strategy
The key elements of the company's strategy are to partner with high-quality nephrologists with strong local market reputation and patient relationships; grow organically through de novo clinics in new and existing markets and expansion of existing clinics; opportunistically pursue acquisitions; and deliver on its core values with comprehensive clinic management services.
Trademarks
The company owns certain trademarks and logos, including AmericanRenal, AmericanRenal Associates, The Nephrologist is the Center of Our Universe and the American Renal Associates logo. Each one of these trademarks or logos is registered with the U.S. Patent and Trademark Office.
Government Regulation
The company’s clinics must obtain and maintain certification from the Centers for Medicare and Medicaid Services to participate in the Medicare and Medicaid programs.
The Health Insurance Portability and Accountability Act of 1996, as amended by the federal Health Information Technology for Economic and Clinical Health Act, and the privacy and security regulations implementing the statute, requires the company to provide certain protections to patients and their protected health information.
Occupational Safety and Health Administration laws and regulations also apply to the company, including those that require employers to provide workers who are occupationally exposed to blood or other infectious materials with prescribed protections.
History
American Renal Associates Holdings, Inc. was founded in 1999.
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
